Anthem Blue Cross (HMO, PPO, EPO)
Faslodex 125 Mg/2.5 Syrg (fulvestrant)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Breast Cancer: HR+ (HER2+):
    Documented Diagnosis: Yes
    Duration: 1 year(s)

  • Breast Cancer: HR+ (HER2+):
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A